Inventor · disambiguated record
Brian J. Lavey
Also filed as: LAVEY BRIAN · LAVEY BRIAN J
28 granted patents·2 pending applications·303 citations·filing 1998–2013
96Inventor score
Top patents by PatentIndex Score
30 records- 0195US7488745B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Feb 10, 2009·23 cites·34 claims
- 0292US8178553B2Compounds for the treatment of inflammatory disordersLAVEY BRIAN J·Filed 2010·Granted May 15, 2012·46 cites·19 claims
- 0392US7524842B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Apr 28, 2009·19 cites·34 claims
- 0492US7504424B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2006·Granted Mar 17, 2009·24 cites·3 claims
- 0591US8569336B2Compounds for the treatment of inflammatory disordersTONG LING·Filed 2009·Granted Oct 29, 2013·44 cites·4 claims
- 0691US7482370B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 27, 2009·20 cites·79 claims
- 0788US7879890B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Feb 1, 2011·6 cites·11 claims
- 0886US7772263B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2009·Granted Aug 10, 2010·7 cites·31 claims
- 0986US7687527B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Mar 30, 2010·8 cites·9 claims
- 1085US9254292B2Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseasesCOBURN CRAIG A·Filed 2011·Granted Feb 9, 2016·9 cites·9 claims
- 1184US7683085B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Mar 23, 2010·6 cites·10 claims
- 1283US9221809B2Aminopyrimidinones as interleukin receptor-associated kinase inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted Dec 29, 2015·4 cites·3 claims
- 1382US7718702B2Cannabinoid receptor ligandsSCHERING CORP·Filed 2005·Granted May 18, 2010·5 cites·34 claims
- 1482US7652020B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 26, 2010·5 cites·48 claims
- 1582US7071213B2Cannabinoid receptor ligandsSCHERING CORP·Filed 2002·Granted Jul 4, 2006·16 cites·20 claims
- 1682US7067539B2Cannabinoid receptor ligandsSCHERING CORP·Filed 2002·Granted Jun 27, 2006·18 cites·31 claims
- 1779US9598440B2Inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2013·Granted Mar 21, 2017·6 cites·5 claims
- 1878US6838466B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2002·Granted Jan 4, 2005·10 cites·41 claims
- 1976US7507767B2Cannabinoid receptor ligandsSCHERING CORP·Filed 2002·Granted Mar 24, 2009·8 cites·37 claims
- 2075US8361959B2Spiro-imidazolone derivatives as glucagon receptor antagonistsMERCK SHARP & DOHME·Filed 2009·Granted Jan 29, 2013·2 cites·18 claims
- 2174US7683088B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Mar 23, 2010·1 cites·19 claims
- 2272US8541572B2Compounds for the treatment of inflammatory disordersKOZLOWSKI JOSEPH A·Filed 2009·Granted Sep 24, 2013·2 cites·4 claims
- 2371US6063926ASubstituted oximes as neurokinin antagonistsSCHERING CORP·Filed 1998·Granted May 16, 2000·14 cites·7 claims
- 2455US7598242B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Oct 6, 2009·0 cites·3 claims
- 2554US7034057B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2003·Granted Apr 25, 2006·0 cites·2 claims
- 2652US7645774B2Cannabinoid receptor ligandsSCHERING CORP·Filed 2005·Granted Jan 12, 2010·0 cites·30 claims
- 2745US8450355B2Compounds for the treatment of inflammatory diseasesWONG MICHAEL K C·Filed 2009·Granted May 28, 2013·0 cites·19 claims
- 2843US8859529B2Compounds for the treatment of inflammatory disordersSHANKAR BANDARPALLE B·Filed 2009·Granted Oct 14, 2014·0 cites·16 claims
- 2937US2013012434A1Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their useWONG MICHAEL K·Filed 2011·Application pending·0 cites
- 3032US2013012493A1Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their useZHAO HE·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →